Cargando…
Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia
BACKGROUND: Botulinum neurotoxin type A (BoNT-A) is an effective pharmacological treatment for the management of cervical dystonia (CD) that requires repeated administration at variable intervals. We explored patient perceptions of the impact of CD and the waning of BoNT-A therapeutic effects. METHO...
Autores principales: | Comella, Cynthia, Ferreira, Joaquim J., Pain, Emilie, Azoulai, Marion, Om, Savary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914227/ https://www.ncbi.nlm.nih.gov/pubmed/32939574 http://dx.doi.org/10.1007/s00415-020-10217-7 |
Ejemplares similares
-
Correction to: Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia
por: Comella, Cynthia, et al.
Publicado: (2020) -
Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020) -
Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020) -
An international survey of patients with cervical dystonia
por: Comella, Cynthia, et al.
Publicado: (2015) -
INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin
por: Misra, Vijay P., et al.
Publicado: (2017)